KENNEDY SPACE CENTER (FL), January 25, 2019 (CASIS PR) – Last night, the Regenerative Medicine Foundation awarded the International Space Station (ISS) U.S. National Laboratory the foundation’s annual Leadership Award for enabling stem cell and regenerative medicine investigations onboard the orbiting laboratory. The award was presented at the 14th annual World Stem Cell Summit in Miami, Florida. Past recipients of this prestigious award include former Vice President Joe Biden and his wife Jill Biden and also Michael J. Fox (The Michael J. Fox Foundation has sent multiple projects to the ISS National Lab aimed at improving the understanding and treatment of Parkinson’s disease). ISS National Lab Board of Directors member Dr. Gordana Vunjak-Novakovic accepted the award on behalf of the organization.
WASHINGTON (NASA PR) — NASA will host a media teleconference at 1 p.m. EST Thursday, Nov. 8, to discuss select science investigations and technology demonstrations launching on the next Northrop Grumman commercial resupply flight to the International Space Station. Audio of the teleconference will stream live on NASA’s website.
Tara Ruttley, associate chief scientist for Microgravity Research in NASA’s Office of Chief Scientist, and Liz Warren, associate program scientist for the station’s National Lab, will provide an overview of the research and technology aboard Northrop Grumman’s Cygnus spacecraft.
Also participating in Thursday’s briefing are:
Laurence Harris is a professor at York University in Toronto and principle investigator for research to develop, in collaboration with the Canadian Space Agency, a mathematical model for how an astronaut’s perception of motion, body position and distance to objects changes in space.
Marco Baptista with the Michael J. Fox Foundation in New York is the principle investigator for a National Lab investigation to evaluate growth of protein crystals implicated in Parkinson’s disease. Crystals grown in space are larger, enabling more detailed analysis to help define the protein’s exact shape and morphology and help scientists better understand the disease’s pathology.
Negar Rajabiat Cemscia, LLC, is principle investigator for National Lab research to test a novel approach of using particles of calcium-silicate to synthesize membranes as thin as a human hair. These particles can separate carbon dioxide molecules from air or other gases, technology that could aid in removing carbon dioxide from waste gases to reduce greenhouse gas emissions.
Tamara Koch, David Merges and Dominik Spahr, principle and co-principle investigators at Goethe University in Frankfurt, Germany, will discuss a National Lab investigation focused on astrophysics research to examine the formation of chondrules, some of the oldest material in the solar system.
To participate in the teleconference, media must contact Joshua Finch at 202-358-1100 or email@example.com by 10 a.m. Nov. 8 for dial-in information.
Northrop Grumman is targeting Thursday, Nov. 15, for its 10th contracted mission under NASA’s Commercial Resupply Services contract. The Cygnus spacecraft will launch on an Antares rocket from the Mid-Atlantic Regional Spaceport’s pad 0A at Wallops Flight Facility in Wallops Island, Virginia, carrying scientific research, crew supplies, and hardware to the orbiting laboratory to support the station’s Expedition 57 and 58 crews.
For launch countdown coverage, NASA’s launch blog, and more information about the mission, visit:
KENNEDY SPACE CENTER, Fla., August 8, 2017 (CASIS PR)– The SpaceX Falcon 9 vehicle is poised to launch its 12th cargo resupply mission (CRS-12) to the International Space Station (ISS) no earlier than August 13th, 2017 from Kennedy Space Center Launch Pad 39A.
The SpaceX Dragon spacecraft will carry more than 20 ISS National Laboratory payloads to conduct research across a variety of areas aimed at improving life on Earth, including research on Parkinson’s disease, new anti-bacterial compounds, new approaches to treating blood pressure, and pioneering new advances in the use of stem cells for repairing damage from disease, among many others. Thus far in 2017, the ISS National Lab has sponsored more than 100 separate experiments that have reached the station.
NEW YORK (MJFF PR) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Center for the Advancement of Science in Space (CASIS) today announce a partnership to send a key Parkinson’s protein to the International Space Station for growth under microgravity conditions. Microgravity may allow bigger, more regular LRRK2 protein crystals to grow, which helps solve the protein’s structure. That information could help scientists design optimized therapies against LRRK2, a key target in the pursuit of a Parkinson’s cure.